Term
|
Definition
CH 20 Drugs Used in Asthma
Beta Agonists
Nonselective α, β1, and β2 agonist; bronchodilation plus all other sympathomimetic effects on cardiovascular and other systems
|
Tachycardia, arrhythmias, worsening angina pectoris
|
Acute vasodilation, shock, and bronchospasm of anaphylaxis
|
|
|
|
Term
|
Definition
CH 20 Drugs Used in Asthma
Beta Agonists
β1 and β2 agonist; bronchodilation & powerful cardiovascular effects
|
Cardiac arrhythmias from high doses ↑ mortality
|
Asthma, but β2 selective preferred
|
|
|
|
Term
|
Definition
CH 20 Drugs Used in Asthma
Beta Agonists
Selective β2 agonist; prompt bronchodilation
|
Tremor, tachycardia, overdose arrhythmias
|
Asthma, COPD, drug of choice in acute asthmatic bronchospasm
|
|
|
|
Term
Metaproterenol
and other "nol and rol"s |
|
Definition
CH 20 Drugs Used in Asthma
Beta Agonists
Selective β2 agonist; prompt bronchodilation
|
Tremor, tachycardia, overdose arrhythmias
|
Asthma, COPD, drug of choice in acute asthmatic bronchospasm
|
|
|
|
Term
|
Definition
CH 20 Drugs Used in Asthma
Beta Agonists
Only β2 agonist available for subcutaneous injection
|
“
|
“
|
|
|
|
Term
|
Definition
CH 20 Drugs Used in Asthma
Corticosteroids (inhaled)
Broad anti-inflammatory efficacy, inhibit production of cytokines; inhibit infiltration of asthmatic airways by lymphocytes, eosinophils, and mast cells
|
Dysphonia
Oropharyngeal candidiasis (opportunistic mucosal fungal infection) – patients must gargle and spit after each use; hoarseness
|
Do not relax smooth muscle directly but reduce bronchial reactivity and frequency of asthmatic exacerbations if taken regularly
|
|
|
|
|
|
Term
|
Definition
CH 20 Drugs Used in Asthma
Corticosteroids (inhaled)
Broad anti-inflammatory efficacy, inhibit production of cytokines; inhibit infiltration of asthmatic airways by lymphocytes, eosinophils, and mast cells
|
Dysphonia
Oropharyngeal candidiasis (opportunistic mucosal fungal infection) – patients must gargle and spit after each use; hoarseness
|
Do not relax smooth muscle directly but reduce bronchial reactivity and frequency of asthmatic exacerbations if taken regularly
|
|
|
|
|
|
Term
|
Definition
CH 20 Drugs Used in Asthma
Corticosteroids (oral)
Systemic, anti-inflammatory
|
*Adrenal suppression Significant adverse side effects – psychiatric and GI symptoms, etc.
|
Many inflammatory diseases including asthma and COPD
|
|
|
|
Term
|
Definition
CH 20 Drugs Used in Asthma
Mast Cell Degranulation Inhibitor
Must be taken prophylactically;
alters function of delayed Cl- channels, thus inhibiting inflammatory cell activation
|
Minor and localized – throat irritation, cough, mouth dryness
|
Allergic rhinoconjunctivitis not as potent as corticosteroids
|
|
|
|
Term
|
Definition
CH 20 Drugs Used in Asthma
Methylxanthines
Uncertain - phosphodiesterase inhibition, adenosine receptor antagonist; bronchodilation, cardiac stimulation, ↑ skeletal muscle strength (diaphragm)
|
Anorexia, nausea, vomiting, abdominal discomfort, headache, anxiety (15-20mg/L plasma); Seizures or arrhythmias (40mg/L)
|
Asthma, COPD narrow therapeutic window
|
|
|
|
Term
|
Definition
CH 20 Drugs Used in Asthma
Leukotriene Antagonists
Block leukotriene D4 receptors; block airway response to exercise and antigen challenge
|
minimal
|
Prophylaxis of asthma, especially in children and in aspirin-induced asthma
|
|
|
|
Term
|
Definition
CH 20 Drugs Used in Asthma
Leukotriene Antagonists
Inhibits lipoxygenase, reduces synthesis of leukotrienes
|
Occasional liver toxicity
|
“
|
|
|
|
Term
|
Definition
CH 20 Drugs Used in Asthma
IgE Antibody
Inhibits binding of IgE to mast cells but does not activate IgE already bound to these cells; reduce frequency and severity of asthmatic exacerbations
|
|
Severe asthma inadequately controlled by other agents
|
|
|
|
Term
|
Definition
CH 20 Drugs Used in Asthma
Antimuscarinic Drugs
Competitively inhibit the effect of acetylcholine at muscarinic receptors; block contraction of airway smooth muscle and the ↑ in secretion of mucus that occurs in response to ACh release from vagal nerves; does not enter CNS
|
Dry mouth, sedation
|
Less effective than β-agonist in reversing asthmatic bronchospasm, but enhances bronchodilation; COPD
|
|
|
|
Term
|
Definition
CH 20 Drugs Used in Asthma
Antimuscarinic Drugs
Longer-acting, selective antimuscarinic agent
|
Dry mouth, throat irritation
|
COPD
|
|
|
|